Do IL-4 intron 3 VNTR and IL-6 (-174) G/C variants reflect ethnic variation? A comparative study between the global and North Indian populations

Asian Pacific Journal of Cancer Prevention

Volumn 9, Issue 1, 2008, Pages 76-80

  Kesarwani, Pravin ^a   Ahirwar, Dinesh ^a   Singh, Ranjana ^a   Manchanda, Parmeet K ^a   Mittal, Rama D ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cytokines; International comparison; Polymorphisms

Indexed keywords

EID: 58349092196     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Akira S, Taga T, Kishimoto T (1993). Interleukin-6 in biology and medicine. Adv Immunol, 54, 1-78
2. Belluco C, Olivieri F, Bonafe M, et al (2003). -174 G>C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer. Clin Cancer Res, 9, 2173-6.
3. Bhanoori M, Babu KA, Deenadayal M, et al (2005). The interleukin-6 -174G/ C promoter polymorphism is not associated with endometriosis in South Indian women. J Soc Gynecol Investig, 12, 365-9.
4. Bid HK, Mishra DK, Mittal RD (2005). Vitamin-D receptor (VDR) gene (Fok-I, Taq-I and Apa-I) polymorphisms in healthy individuals from north Indian population. Asian Pac J Cancer Prev, 6, 147-52.
5. Bowcock AM, Kidd JR, Lathrop GM, et al (1988). The human "interferon-beta 2/hepatocyte stimulating factor/ interleukin-6" gene: DNA polymorphism studies and localization to chromosome 7p21. Genomics, 3, 8-16.
6. Buchs N, Silvestri T, di Giovine FS, et al (2000). IL-4 VNTR gene polymorphism in chronic polyarthritis. The rare allele is associated with protection against destruction. Rheumatology (Oxford), 39, 1126-31.
7. Bushley AW, Ferrell R, McDuffie K et al (2004). Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer. Gynecol Oncol, 95, 672-9.
8. Coon CS (1983). Human populations. In: New Encyclopedia Britannica (University of Chicago, USA) 14, 839.
9. Fernandez-Real JM, Vendrell J, Richart C, et al (2001). Platelet count and interleukin 6 gene polymorphism in healthy subjects. BMC Med Genet, 2, 6.
10. Fishman D, Faulds G, Jeffery R, et al (1998). The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest, 102, 1369-76.
11. Halverstadt A, Phares DA, Roth S, et al (2005). Interleukin-6 genotype is associated with high-density lipoprotein cholesterol responses to exercise training. Biochim Biophys Acta, 1734, 143-51.
12. Hegab AE, Sakamoto T, Saitoh W, et al (2004). Polymorphisms of IL4, IL13, and ADRB2 genes in COPD. Chest, 126, 1832-9.
13. Hirano T, Yasukawa K, Harada H, et al (1986). Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature, 324, 73-6.
14. Hong CJ, Yu YW, Chen TJ et al (2005). Interleukin-6 genetic polymorphism and Chinese major depression. Neuropsychobiology, 52, 202-5.
15. Ishibashi T, Kimura H, Uchida T, et al (1989). Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro. Proc Natl Acad Sci, 86, 5953-7.
16. Jeng JR, Wang JH, Liu WS, et al (2005). Association of interleukin-6 gene G-174C polymorphism and plasma plasminogen activator inhibitor-1 level in Chinese patients with and without hypertension. Am J Hypertens, 18, 517-22.
17. Kidd P (2003). Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev, 8, 223-46.
18. Kishimoto T (1989). The biology of Interleukine-6. Blood, 74, 1-10.
19. Landi S, Moreno V, Gioia-Patricola L, et al (2003). Association of common polymorphisms in inflammatory genes interleukin (IL) 6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res, 63, 3560-6.
20. Matsumoto K, Kanmatsuse K (2000). Interleukin-18 and interleukin-12 synergize to stimulate the production of vascular permeability factor by T lymphocytes in normal subjects and in patients with minimal-change nephrotic syndrome. Nephron, 85, 127-33.
21. Mazur G, Bogunia-Kubik K, Wrobel T, et al (2005). IL-6 and IL-10 promoter gene polymorphisms do not associate with the susceptibility for multiple myeloma. Immunol Lett, 96, 241-6.
22. Meenagh A, Williams F, Ross OA, et al. (2002). Frequency of cytokine polymorphisms in populations from western Europe, Africa,Asia, the Middle East and South America. Hum Immunol 63, 1055-61
23. Michaud DS, Daugherty SE, Berndt SI, et al (2006). Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer. Cancer Res, 66, 4525-30.
24. Miller SA, Dykes DD, Polesky HF (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res, 16, 1215.
25. Mittal RD, Manchanda PK (2007). Association of interleukin (IL)-4 intron-3 and IL-6 -174 G/C gene polymorphism with susceptibility to end-stage renal disease. Immunogenetics. 59, 159-65.
26. Mout R, Willemze R, Landegent JE (1991). Repeat polymorphisms in the interleukin-4 gene (IL4). Nucleic Acids Res, 19, 3763.
27. Nakashima H, Miyake K, Inoue Y, et al (2002). Association between IL-4 genotype and IL-4 production in the Japanese population. Genes Immun, 3, 107-9.
28. Nogueira de Souza NC, Brenna SM, Campos F, et al (2006). Interleukin-6 polymorphisms and the risk of cervical cancer. Int J Gynecol Cancer, 16, 1278-82.
29. Sosroseno W, Herminajeng E, Goeno S (1994). The interleukin network in the immunopathogenesis of oral disease. Asian Pas. J of allergy Immunology, 12, 161-8.
30. Stenvinkel P, Ketteler M, Johnson RJ, et al (2005). IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly. Kidney Int, 67, 1216-33.
31. Su SY, Chen JJ, Lai CC, et al (2007). The association between fibromyalgia and polymorphism of monoamine oxidase A and interleukin-4. Clin Rheumatol, 26, 12-6.
32. Tan D, Wu X, Hou M, et al (2005). Interleukin-6 polymorphism is associated with more aggressive prostate cancer. J Urol, 174, 753-6.
33. Vasku JA, Vasku A, Goldbergova M, et al (2004). Heterozygote AG variant of -596 A/G IL-6 gene polymorphism is a marker for cutaneous T-cell lymphoma (CTCL). Clin Immunol, 113, 256-60.